Searchable abstracts of presentations at key conferences in endocrinology

ea0048o9 | Oral Communications | SFEEU2017

Retroperitoneal fibrosis presenting with panhypopituitarism

Talla Maria , McGeoch Lucy , Carty David

Case History: A 68-year-old gentleman with hypertension and diet-controlled type 2 diabetes presented in September 2015 with weight loss, fatigue, low libido and cold intolerance.Investigations: Blood results demonstrated secondary hypothyroidism (TSH 0.59 mU/l (reference range 0.35–5.00), free T4 8.3 pmol/l (ref 9.0–21.0)), hypogonadotrophic hypogonadism (testosterone 1.0 nmol/l (ref 10.0–36.0), FSH 1.5, LH 1.1) and a modestly elevated pr...

ea0044s2.3 | Grappling with the future of anti-inflammatory steroids | SFEBES2016

Effective delivery of anti-inflammatory glucocorticoids is a matter of timing

Gibbs Julie , Loudon Andrew , Ray David

The circadian clock is a key regulator of immune responses. Both circulating and resident immune cells possess intrinsic timers, which act to impart time-of-day variation in their function. It is now becoming evident that the circadian clock is also critically involved in regulating the function of endogenous anti-inflammatory glucocorticoid hormones. Consequently, we see variation in an animal’s inflammatory responses dependent on the time the stimulus was delivered. Thi...

ea0044p77 | Clinical biochemistry | SFEBES2016

Nine year evaluation of a recall database of thyroid function tests in a combined antenatal-endocrine clinic

Khalily Naveed , Hodgett Sheena , Barton David

Thyroid dysfunction is associated with well-recognised maternal and fetal complications. There is an increase in thyroxine requirement during pregnancy by 25–50% hence close monitoring of thyroid function and dose augmentation is vital in attaining euthyroid status. In our combined antenatal-endocrine clinic we aim to test thyroid function tests (TFTs) at booking, in the second and third trimesters. In order to reduce the need for patients to re-attend the clinic purely f...

ea0059p046 | Bone and calcium | SFEBES2018

Role of Ultrasound Neck (US), sestamibi Scintigraphy and Multidisciplinary team (MDT) discussion prior to intervention in the localization of parathyroid lesion

Ahmed Syed , Shakeel Majeed Muhammad , Till David

Background: Primary hyperparathyroidism is an endocrine disorder characterized by autonomous production of parathyroid hormone (PTH) results in the derangement of calcium metabolism. Imaging modalities used to localize includes technetium-99m sestamibi, sestamibi-single photon emission computed tomography (SPECT), SPECT-CT fusion, ultrasound Neck and Four dimensional computed tomography (4D-CT). Sestamibi scintigraphy combined with sestamibi single photon emission computed tom...

ea0059ep97 | Thyroid | SFEBES2018

The Use of Salvage Radiotherapy and Radioactive Iodine in a Case of Recurrent Metastatic Papillary Thyroid Cancer: A Case Report

Tansey David J , Gibney James , Salib Osama

Background: Thyroid carcinoma consists of just 1% of all malignancies but is the commonest malignant endocrine tumour. Papillary thyroid carcinoma is the most common form of thyroid carcinoma consisting of 80% of all cases. There are very few case reports in the literature of papillary thyroid cancers presenting with distant to the pelvic organs. Distant metastases are noted in 1–3% of patients with thyroid cancer at initial diagnosis.Clinical case:...

ea0038p89 | Clinical practice/governance and case reports | SFEBES2015

Adrenal insufficiency caused by bilateral primary adrenal lymphoma

Mackin Sharon , Carty David , Drummond Russell

Primary adrenal lymphoma is rare and accounts for <1% of extra-nodal non-Hodgkin’s lymphoma cases. It presents with B symptoms, bilateral adrenal masses and hypoadrenalism; and thought to have a poor prognosis. We describe a patient that was diagnosed with and successfully treated for primary adrenal diffuse large B cell lymphoma (DLBCL).Case: A 62-year-old gentleman with longstanding hypertension presented with a 5-month history of weight loss,...

ea0038p336 | Pituitary | SFEBES2015

A case of pituitary functional recovery in a patient with Langerhan’s cell histiocytosis following chemotherapy with chlorodeoxyadenosine and mercaptopurine

Ghabbour Andrew , Herring Roselle , Russelll-Jones David

Introduction: Langerhans cell histiocytosis (LCH) is a rare multisystem disease. Pituitary manifestations include failure of the anterior and/or posterior pituitary, with diabetes insipidus and gonadotrophine deficiency being most prevalent. We present a case of a female who had pituitary failure yet conceived naturally following chemotherapy.Case description: A 24-year-old female presented with polydipsia, polyuria, and lethargy. A water deprivation tes...

ea0035p974 | Thyroid (non-cancer) | ECE2014

Management of hypothyroidism in pregnancy

Bohacikova Andrea , Bullimore David , Pereira Olivia

Until 12th week of gestation foetus is entirely dependent on maternal thyroxine. Inadequate thyroxine replacement may lead to lower IQ of offspring and also an increased miscarriage rate.We audited 68 hypothyroid pregnant females to assess whether management of their thyroid status had met current standards. In the first trimester TSH is not an optimal monitoring marker as it is supressed by rising HCG level. According to established clinical guidelines ...

ea0034p21 | Bone | SFEBES2014

Predictors of postoperative hypocalcaemia in parathyroidectomy patients: local audit

Katreddy Venkata , Blundell David , Buch Harit

Introduction: Parathyroidectomy is the treatment of choice for patients with primary hyperparathyroidism who have significant hypercalcemia and/or end-organ damage. The incidence of postoperative hypocalcaemia is 25–90% in patients with evidence of radiological evidence of parathyroid disease, 0–6% without. In most patients it is mild, but in some, it can cause significant morbidity. It has been attributed as ‘hungry-bone syndrome’ and attempts have been ma...

ea0034p159 | Growth and development | SFEBES2014

Identification and characterisation of human foetal adrenocortical progenitor cells

Sampson Jessica , Wilson David , O'Kelly Ita

The human foetal adrenal gland (HFA) comprises of two distinct zones; the foetal zone (FZ) and the definitive zone (DZ). The subcapsular DZ has been proposed to contain a population of adrenocortical progenitors that migrate centripetally to populate the FZ. Rodent studies have identified sonic hedgehog (SHH) signalling in a subcapsular non-steroidogenic progenitor population and its disruption during development causes adrenal hypoplasia. The involvement of SHH in the human f...